{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:43:15Z","timestamp":1790800995887,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd013792","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000}}],"reference-count":123,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013792.pub2","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T01:29:31Z","timestamp":1618882171000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Progestogens for preventing miscarriage: a network meta-analysis"],"prefix":"10.1002","volume":"2021","author":[{"given":"Adam J","family":"Devall","sequence":"additional","affiliation":[{"name":"Tommy\u2019s National Centre for Miscarriage Research, Institute of Metabolism and Systems Research (IMSR), WHO Collaborating Centre for Global Women\u2019s Health Research; University of Birmingham; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyro","family":"Papadopoulou","sequence":"additional","affiliation":[{"name":"Tommy\u2019s National Centre for Miscarriage Research, Institute of Metabolism and Systems Research (IMSR), WHO Collaborating Centre for Global Women\u2019s Health Research; University of Birmingham; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelina","family":"Podesek","sequence":"additional","affiliation":[{"name":"Tommy\u2019s National Centre for Miscarriage Research, Institute of Metabolism and Systems Research (IMSR), WHO Collaborating Centre for Global Women\u2019s Health Research; University of Birmingham; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Haas","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology; Indiana University School of Medicine; Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm J","family":"Price","sequence":"additional","affiliation":[{"name":"Test Evaluation Research Group, Institute of Applied Health Research; University of Birmingham; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arri","family":"Coomarasamy","sequence":"additional","affiliation":[{"name":"Tommy\u2019s National Centre for Miscarriage Research, Institute of Metabolism and Systems Research (IMSR), WHO Collaborating Centre for Global Women\u2019s Health Research; University of Birmingham; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis D","family":"Gallos","sequence":"additional","affiliation":[{"name":"Tommy\u2019s National Centre for Miscarriage Research, Institute of Metabolism and Systems Research (IMSR), WHO Collaborating Centre for Global Women\u2019s Health Research; University of Birmingham; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"key":"10.1002\/14651858.CD013792.pub2-BIB0001|cit1","first-page":"DOI: 10.1093\/hu","article-title":"Use of oral progestogen in women with threatened miscarriage in the first trimester: a randomized double-blind controlled trial","volume":"Online ahead of","author":"Chan","year":"2020","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD013792.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s13063-016-1509-8","article-title":"A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial","volume":"17","author":"Chan","year":"2016","journal-title":"Trials"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0003|cit3","unstructured":"Chan DM NCT02128685: Randomized double-blind controlled trial of use of dydrogesterone in threatened miscarriage https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02128685"},{"issue":"2","key":"10.1002\/14651858.CD013792.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ajog.2019.12.006","article-title":"Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence","volume":"223","author":"Coomarasamy","year":"2020","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"22","key":"10.1002\/14651858.CD013792.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1056\/NEJMoa1504927","article-title":"A randomized trial of progesterone in women with recurrent miscarriages","volume":"373","author":"Coomarasamy","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"41","key":"10.1002\/14651858.CD013792.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20410","article-title":"PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation","volume":"20","author":"Coomarasamy","year":"2016","journal-title":"Health Technology Assessment (Winchester, England)"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0007|cit7","doi-asserted-by":"crossref","unstructured":"Coomarasamy A ISRCTN92644181: Progesterone in recurrent miscarriages(PROMISE) study https:\/\/doi.org\/10.1186\/ISRCTN92644181","DOI":"10.1186\/ISRCTN92644181"},{"issue":"19","key":"10.1002\/14651858.CD013792.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMoa1813730","article-title":"A randomized trial of progesterone in women with bleeding in early pregnancy","volume":"380","author":"Coomarasamy","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"33","key":"10.1002\/14651858.CD013792.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta24330","article-title":"Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT","volume":"24","author":"Coomarasamy","year":"2020","journal-title":"Health Technology Assessment (Winchester, England)"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0010|cit10","doi-asserted-by":"crossref","unstructured":"Coomarasamy A ISRCTN14163439: PRISM: Progesterone in spontaneous miscarriage https:\/\/doi.org\/10.1186\/ISRCTN14163439","DOI":"10.1186\/ISRCTN14163439"},{"issue":"1","key":"10.1002\/14651858.CD013792.pub2-BIB0011|cit11","first-page":"26","article-title":"Double-blind controlled trial of progesterone substitution in threatened abortion","volume":"8","author":"Gerhard","year":"1987","journal-title":"Biological Research in Pregnancy & Perinatology"},{"issue":"3","key":"10.1002\/14651858.CD013792.pub2-BIB0012|cit12","first-page":"394","article-title":"Cervical mucus, vaginal cytology and steroid excretion in recurrent abortion","volume":"40","author":"MacDonald","year":"1972","journal-title":"Obstetrics & Gynecology"},{"issue":"5326","key":"10.1002\/14651858.CD013792.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bmj.1.5326.292","article-title":"Double-blind study of effect of 17-hydroxyprogesterone caproate on abortion rate","volume":"1","author":"Shearman","year":"1963","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0014|cit14","unstructured":"Chye TT ChiCTR-IOR-17011593. The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage chictr.org.cn\/showproj.aspx?proj=19668 (first received 6 July 2017)"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0015|cit15","unstructured":"Chye TT ChiCTR-IPR-14005251. Micronised progesterone versus dydrogesterone: a randomised controlled trial chictr.org.cn\/showproj.aspx?proj=9539 (first received 21 September 2014)"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0016|cit16","first-page":"276","article-title":"Biochemical and clinical outcomes following the use of micronised progesterone and dydrogesterone for threatened miscarriage - A randomised controlled trial","volume":"122","author":"Hui","year":"2015","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ejogrb.2018.07.028","article-title":"The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage","volume":"228","author":"Siew","year":"2018","journal-title":"European Journal of Obstetrics, Gynecology, & Reproductive Biology"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0018|cit18","first-page":"243","article-title":"Progestogen for threatened miscarriage: a randomised controlled trial comparing micronised progesterone and dydrogesterone","volume":"27","author":"Siew","year":"2014","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"104S","DOI":"10.1097\/01.AOG.0000463637.28791.c1","article-title":"Micronized progesterone compared with dydrogesterone for threatened miscarriage: a randomized controlled trial","volume":"125","author":"Siew","year":"2015","journal-title":"Obstetrics and gynecology"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ijgo.13148","article-title":"Effect of adjunctive vaginal progesterone after McDonald cerclage on the rate of second-trimester abortion in singleton pregnancy: a randomized controlled trial","volume":"149","author":"Ali","year":"2020","journal-title":"International Journal of Gynaecology & Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD013792.pub2-BIB0021|cit21","first-page":"162","article-title":"Comparison of risk of preterm labor between vaginal progesterone and 17-Alpha-Hydroxy-Progesterone Caproate in women with threatened abortion: a randomized clinical trial","volume":"10","author":"Beigi","year":"2016","journal-title":"International Journal of Fertility & Sterility"},{"issue":"1-4","key":"10.1002\/14651858.CD013792.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF00679447","article-title":"[The treatment of imminent abortion with monitoring of the maternal serum HPL level (proceedings)]","volume":"224","author":"Berle","year":"1977","journal-title":"Archiv fur Gynakologie"},{"issue":"5","key":"10.1002\/14651858.CD013792.pub2-BIB0023|cit23","first-page":"353","article-title":"[Is hormonal therapy still justified in imminent abortion? (author's transl)]","volume":"184","author":"Berle","year":"1980","journal-title":"Zeitschrift fur Geburtshilfe und Perinatologie"},{"issue":"3","key":"10.1002\/14651858.CD013792.pub2-BIB0024|cit24","first-page":"45","article-title":"Decreased abortions in HMG-induced pregnancies with prophylactic progesterone therapy","volume":"30","author":"Check","year":"1985","journal-title":"International Journal of Fertility"},{"issue":"2","key":"10.1002\/14651858.CD013792.pub2-BIB0025|cit25","first-page":"135","article-title":"The efficacy of progesterone in achieving successful pregnancy: I. Prophylactic use during luteal phase in anovulatory women","volume":"32","author":"Check","year":"1987","journal-title":"International Journal of Fertility"},{"issue":"2","key":"10.1002\/14651858.CD013792.pub2-BIB0026|cit26","first-page":"139","article-title":"The efficacy of progesterone in achieving successful pregnancy: II. In women with pure luteal phase defects","volume":"32","author":"Check","year":"1987","journal-title":"International Journal of Fertility"},{"issue":"3","key":"10.1002\/14651858.CD013792.pub2-BIB0027|cit27","first-page":"192","article-title":"Progesterone therapy to decrease first-trimester spontaneous abortions in previous aborters","volume":"32","author":"Check","year":"1987","journal-title":"International Journal of Fertility"},{"issue":"4","key":"10.1002\/14651858.CD013792.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000292421","article-title":"A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment versus progesterone alone in primary habitual aborters","volume":"39","author":"Check","year":"1995","journal-title":"Gynecologic & Obstetric Investigation"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejogrb.2019.04.012","article-title":"Vaginal progesterone gel is non-inferior to intramuscular progesterone in efficacy with acceptable tolerability for luteal phase support: A prospective, randomized, multicenter study in China","volume":"237","author":"Chi","year":"2019","journal-title":"European Journal of Obstetrics, Gynecology, & Reproductive Biology"},{"issue":"7045","key":"10.1002\/14651858.CD013792.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1136\/bmj.312.7045.1508","article-title":"Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial","volume":"312","author":"Clifford","year":"1996","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD013792.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0301-2115(01)00418-3","article-title":"A randomised trial of progesterone prophylaxis after midtrimester amniocentesis","volume":"100","author":"Corrado","year":"2002","journal-title":"European Journal of Obstetrics, Gynecology, & Reproductive Biology"},{"issue":"8","key":"10.1002\/14651858.CD013792.pub2-BIB0032|cit32","first-page":"1656","article-title":"Resolution of subchorionic hematoma and symptoms of threatened miscarriage using vaginal alpha lipoic acid or progesterone: clinical evidences","volume":"20","author":"Costantino","year":"2016","journal-title":"European Review for Medical & Pharmacological Sciences"},{"issue":"2","key":"10.1002\/14651858.CD013792.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0002-9378(88)90127-5","article-title":"Progesterone profiles in luteal phase defect cycles and outcome of progesterone treatment in patients with recurrent spontaneous abortion","volume":"158","author":"Daya","year":"1988","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD013792.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.fertnstert.2018.07.026","article-title":"Three-arm RCT: vaginal only progesterone is inferior, but vaginal plus intramuscular (IM) progesterone every third day is equivalent, to daily IM progesterone for vitrified-warmed blastocyst transfer in terms of live birth","volume":"110","author":"Devine","year":"2018","journal-title":"Fertility and Sterility. Conference: 74th annual congress of the American Society for Reproductive Medicine, ASRM 2018. Denver Colorado, United States"},{"issue":"5","key":"10.1002\/14651858.CD013792.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jsbmb.2005.08.007","article-title":"Dydrogesterone in the reduction of recurrent spontaneous abortion","volume":"97","author":"El-Zibdeh","year":"2005","journal-title":"Journal of Steroid Biochemistry & Molecular Biology"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.maturitas.2009.11.013","article-title":"Dydrogesterone support in threatened miscarriage","volume":"65 Suppl 1","author":"El-Zibdeh","year":"2009","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0037|cit37","unstructured":"Prospective, double-blind, randomised, placebo controlled, phase III clinical study assessing the efficacy of natural progesterone 25 mg\/bid administered subcutaneously in the maintenance of early pregnancy in women with symptoms of threatened abortion https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02950935"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0038|cit38","unstructured":"Prospective, double-blind, randomised, placebo controlled, phase III clinical study assessing the efficacy of natural progesterone 25 mg\/bid administered subcutaneously in the maintenance of early pregnancy in women with symptoms of threatened abortion https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2016-002777-35"},{"issue":"49","key":"10.1002\/14651858.CD013792.pub2-BIB0039|cit39","first-page":"1461","article-title":"An attempted double-blind controlled trial of progesterone therapy in habitual abortion","volume":"128","author":"Fuchs","year":"1966","journal-title":"Ugeskrift for Laeger"},{"issue":"7","key":"10.1002\/14651858.CD013792.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.1964.03060330031008","article-title":"Double-blind trial of a progestin in habitual abortion","volume":"188","author":"Goldzieher","year":"1964","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD013792.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1471-0528.1965.tb01536.x","article-title":"A double-blind study of progestogen treatment in spontaneous abortion. (Preliminary report)","volume":"72","author":"Govaerts-Videtzky","year":"1965","journal-title":"Journal of Obstetrics & Gynaecology of the British Commonwealth"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0042|cit42","first-page":"i194","article-title":"Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage, a randomized double-blind controlled trial","volume":"30","author":"Ismail","year":"2015","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD013792.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/14767058.2017.1286315","article-title":"Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial","volume":"31","author":"Ismail","year":"2018","journal-title":"Journal of Maternal-Fetal & Neonatal Medicine"},{"issue":"14","key":"10.1002\/14651858.CD013792.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM197510022931401","article-title":"Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor","volume":"293","author":"Johnson","year":"1975","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1471-0528.1965.tb01533.x","article-title":"Hormones in recurrent abortion","volume":"72","author":"Klopper","year":"1965","journal-title":"Journal of Obstetrics and Gynaecology of the British Commonwealth"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0046|cit46","first-page":"30","article-title":"Habitual abortion. A controlled clinical study of progestational therapy","volume":"72","author":"LeVine","year":"1964","journal-title":"Western Journal of Surgery"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0047|cit47","first-page":"1457","article-title":"[Treatment of threatened abortion with methylprogesterone acetate]","volume":"128","author":"Moller","year":"1966","journal-title":"Ugeskrift for Laeger"},{"issue":"2","key":"10.1002\/14651858.CD013792.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humrep\/17.2.357","article-title":"Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial","volume":"17","author":"Nyboe Andersen","year":"2002","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD013792.pub2-BIB0049|cit49","first-page":"1020","article-title":"Oral dydrogesterone vs. micronized vaginal progesterone gel for luteal phase support in frozen-thawed single blastocyst transfer in good prognosis patients","volume":"50","author":"Ozer","year":"2020","journal-title":"Journal of Gynecology Obstetrics and Human Reproduction"},{"issue":"18","key":"10.1002\/14651858.CD013792.pub2-BIB0050|cit50","first-page":"3426","article-title":"Alpha Lipoic Acid (ALA) effects on subchorionic hematoma: preliminary clinical results","volume":"19","author":"Porcaro","year":"2015","journal-title":"European Review for Medical & Pharmacological Sciences"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humrep\/7.suppl_1.1","article-title":"The effect of 17 alpha-hydroxyprogesterone caproate\/oestradiol valerate on the development and outcome of early pregnancies following in vitro fertilization and embryo transfer: a prospective and randomized controlled trial","volume":"7 Suppl 1","author":"Prietl","year":"1992","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"14","key":"10.1002\/14651858.CD013792.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1080\/14767058.2017.1330406","article-title":"Effectiveness of dydrogesterone, 17-OH progesterone and micronized progesterone in prevention of preterm birth in women with a short cervix","volume":"31","author":"Pustotina","year":"2018","journal-title":"Journal of Maternal-Fetal & Neonatal Medicine"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0053|cit53","first-page":"26","article-title":"Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial","volume":"26","author":"Rehal","year":"2020","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD013792.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1471-0528.1988.tb12797.x","article-title":"Endocrine effects of 17 alpha-hydroxyprogesterone caproate during early pregnancy: a double-blind clinical trial","volume":"95","author":"Reijnders","year":"1988","journal-title":"British Journal of Obstetrics & Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD013792.pub2-BIB0055|cit55","first-page":"414","article-title":"[Clinical observation on effect of Chinese herbal medicine plus human chorionic gonadotropin and progesterone in treating anticardiolipin antibody-positive early recurrent spontaneous abortion]","volume":"22","author":"Shu","year":"2002","journal-title":"Chinese Journal of Integrated Traditional & Western Medicine"},{"issue":"12","key":"10.1002\/14651858.CD013792.pub2-BIB0056|cit56","first-page":"1227","article-title":"Treatment with progesterone in threatened abortion and low level of serum progesterone. A double blind randomized trial","volume":"13","author":"Sondergaard","year":"1985","journal-title":"Contraception Fertilite Sexualite"},{"issue":"11","key":"10.1002\/14651858.CD013792.pub2-BIB0057|cit57","first-page":"1025","article-title":"[The fetus protection effects of Zhixue Baotai Decoction on women of early threatened abortion with dark area surrounding pregnancy sac]","volume":"27","author":"Song","year":"2007","journal-title":"Chinese Journal of Integrated Traditional & Western Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013792.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0090-6980(80)90080-5","article-title":"Therapeutic value of indomethacin in threatened abortion","volume":"19","author":"Souka","year":"1980","journal-title":"Prostaglandins"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bmj.1.4819.1073","article-title":"Progesterone implantation in habitual abortion","volume":"1","author":"Swyer","year":"1953","journal-title":"BMJ"},{"issue":"8206","key":"10.1002\/14651858.CD013792.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(80)92496-4","article-title":"Progestagens in threatened abortion","volume":"2","author":"Tognoni","year":"1980","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejogrb.2014.11.002","article-title":"Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial","volume":"186","author":"Tomic","year":"2015","journal-title":"European Journal of Obstetrics, Gynecology, & Reproductive Biology"},{"issue":"4","key":"10.1002\/14651858.CD013792.pub2-BIB0062|cit62","first-page":"251","article-title":"[Clinical and experimental study on yun'an granule in treating threatened abortion]","volume":"20","author":"Zhang","year":"2000","journal-title":"Chinese Journal of Integrated Traditional & Western Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013792.pub2-BIB0063|cit63","first-page":"407","article-title":"Role of progesterone in the treatment of threatened miscarriage in first trimester","volume":"25","author":"Abrar","year":"2017","journal-title":"Journal of Medical Sciences (Peshawar)"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0064|cit64","unstructured":"Agarwal N Role of inflammatory markers in recurrent pregnancy loss and effect of oral micronized therapy on these cases http:\/\/www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=14740"},{"issue":"1-2","key":"10.1002\/14651858.CD013792.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jri.2013.01.004","article-title":"Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations","volume":"98","author":"Alimohamadi","year":"2013","journal-title":"Journal of Reproductive Immunology"},{"issue":"3","key":"10.1002\/14651858.CD013792.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.fertnstert.2006.07.1506","article-title":"Uteroplacental circulation in early pregnancy complicated by threatened abortion supplemented with vaginal micronized progesterone or oral dydrogesterone","volume":"87","author":"Czajkowski","year":"2007","journal-title":"Fertility & Sterility"},{"issue":"7","key":"10.1002\/14651858.CD013792.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/jog.12456","article-title":"Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study","volume":"40","author":"Ghosh","year":"2014","journal-title":"Journal of Obstetrics & Gynaecology Research"},{"issue":"5","key":"10.1002\/14651858.CD013792.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.fertnstert.2014.07.1251","article-title":"Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial","volume":"102","author":"Kumar","year":"2014","journal-title":"Fertility & Sterility"},{"issue":"5","key":"10.1002\/14651858.CD013792.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jsbmb.2005.08.013","article-title":"Dydrogesterone in threatened abortion: pregnancy outcome","volume":"97","author":"Omar","year":"2005","journal-title":"Journal of Steroid Biochemistry & Molecular Biology"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1196\/annals.1335.022","article-title":"Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy","volume":"1034","author":"Palagiano","year":"2004","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.maturitas.2009.11.016","article-title":"Dydrogesterone in threatened miscarriage: a Malaysian experience","volume":"65 Suppl 1","author":"Pandian","year":"2009","journal-title":"Maturitas"},{"issue":"4","key":"10.1002\/14651858.CD013792.pub2-BIB0072|cit72","first-page":"281","article-title":"Treatment possibilities using progestagens and progesteron-like preparations in threatened abortion","volume":"69","author":"Vincze","year":"2006","journal-title":"Magyar Noorvosok Lapja"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0073|cit73","first-page":"E196","article-title":"To study the impact of progesterone (dydrogesterone) on proinflammatory (IL-6 and TNF-alpha) and antiinflammatory (IL-10) cytokines in threatened abortion","volume":"131","author":"Yadav","year":"2015","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD013792.pub2-BIB0074|cit74","first-page":"147","article-title":"The effect of progesterone suppositories on threatened abortion: a randomized clinical trial","volume":"15","author":"Yassaee","year":"2014","journal-title":"Journal of Reproduction & Infertility"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0075|cit75","unstructured":"In women with threatened miscarriage, does progesterone supplementation increase the likelihood of live birth? https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=336813"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0076|cit76","unstructured":"Chinese herbal medicine and micronized progesterone for threatened miscarriage: an international cooperation multicenter randomized controlled trial http:\/\/www.chictr.org.cn\/showproj.aspx?proj=12677"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0077|cit77","unstructured":"A clinical trial to study the effects of two drugs dydrogesterone and micronized progesterone in pregnant women with threatened abortion http:\/\/www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=38656"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0078|cit78","unstructured":"The effect of dydrogesterone and micronized progesterone on threatened abortion http:\/\/en.irct.ir\/trial\/33884"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0079|cit79","unstructured":"The effect of dydrogesterone and Cyclogest on threatened abortion http:\/\/en.irct.ir\/trial\/32531"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0080|cit80","unstructured":"Comparison of the effect of two progesteron drugs in protection of abortion http:\/\/en.irct.ir\/trial\/30167"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0081|cit81","unstructured":"Evaluation of the effect of oral dydrogesterone (Duphaston) in threatened abortion at first trimester http:\/\/en.irct.ir\/trial\/28300"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0082|cit82","unstructured":"Progesterone for the prevention of miscarriage and preterm birth in women with first trimester bleeding: PREEMPT Trial https:\/\/ClinicalTrials.gov\/show\/NCT02145767"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0083|cit83","unstructured":"Vaginal progesterone for treatment of threatened miscarriage https:\/\/ClinicalTrials.gov\/show\/NCT02690129"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0084|cit84","unstructured":"Progesterone supplementation in threatened abortion https:\/\/clinicaltrials.gov\/show\/NCT03930212"},{"issue":"6","key":"10.1002\/14651858.CD013792.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/00016340600627022","article-title":"Cumulative incidence of previous spontaneous abortion in Sweden in 1983-2003: a register study","volume":"85","author":"Adolfsson","year":"2006","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-4471-1918-0_2","volume-title":"Spontaneous Abortion: Diagnosis and Treatment","author":"Alberman","year":"1992"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0087|cit87","first-page":"hoy004","article-title":"ESHRE guideline: recurrent pregnancy loss","volume":"2","author":"Bender Atik","year":"2018","journal-title":"Human Reproduction Open"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jclinepi.2017.10.005","article-title":"Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis","volume":"93","author":"Brignardello-Petersen","year":"2018","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD013792.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Butcher","year":"1997","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7521","key":"10.1002\/14651858.CD013792.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0091|cit91","first-page":"1","article-title":"Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom","volume":"1","author":"Cantwell","year":"2011","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"944\u201352","DOI":"10.1111\/anae.13938","article-title":"Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trials in anaesthetic and general medical journals","volume":"72","author":"Carlisle","year":"2017","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1536867X1501500402","article-title":"Visualizing assumptions and results in network meta-analysis: the network graphs package","volume":"15","author":"Chaimani","year":"2015","journal-title":"Stata Journal"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jclinepi.2016.11.015","article-title":"Additional considerations are required when preparing a protocol for a systematic review with multiple interventions","volume":"83","author":"Chaimani","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4812","key":"10.1002\/14651858.CD013792.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/bmj.1.4812.687","article-title":"Action of the ovarian hormones on uterine muscle","volume":"1","author":"Corner","year":"1953","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.3283939","article-title":"The steroid and thyroid hormone receptor superfamily","volume":"240","author":"Evans","year":"1988","journal-title":"Science"},{"issue":"4","key":"10.1002\/14651858.CD013792.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"367.E1","DOI":"10.1016\/j.ajog.2019.10.102","article-title":"Posttraumatic stress, anxiety and depression following miscarriage and ectopic pregnancy: a multicenter, prospective, cohort study","volume":"222","author":"Farren","year":"2019","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD013792.pub2-BIB0099|cit99","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003511.pub5","article-title":"Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology","author":"Haas","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0100|cit100","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.training.cochrane.org\/handbook"},{"issue":"11","key":"10.1002\/14651858.CD013792.pub2-BIB0101|cit101","first-page":"2120","article-title":"Trends in the incidence, rate and treatment of miscarriage-nationwide register-study in Finland, 1998-2016","volume":"34","author":"Linnakaari","year":"2019","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0102|cit102","first-page":"170","article-title":"Risk factors for first trimester miscarriage\u2014results from a UK-population-based case\u2013control study","volume":"114","author":"Maconochie","year":"2007","journal-title":"Epidemiology"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"l869","DOI":"10.1136\/bmj.l869","article-title":"Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study","volume":"364","author":"Magnus","year":"2019","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD013792.pub2-BIB0104|cit104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008679.pub2","article-title":"Follow-up for improving psychological well being for women after a miscarriage","author":"Murphy","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD013792.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/rmb2.12088","article-title":"Decidualization of the human endometrium","volume":"17","author":"Okada","year":"2018","journal-title":"Reproductive Medicine and Biology"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13048-015-0205-8","article-title":"Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue?","volume":"8","author":"Palomba","year":"2015","journal-title":"Journal of Ovarian Research"},{"issue":"11","key":"10.1002\/14651858.CD013792.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1210\/jc.2013-3937","article-title":"Progesterone pharmacokinetics and pharmacodynamics with 3 dosages and 2 regimens of an effervescent micronized progesterone vaginal insert","volume":"99","author":"Paulson","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.steroids.2019.02.009","article-title":"Immunomodulatory effects of progesterone and selective ligands of membrane progesterone receptors","volume":"145","author":"Polikarpova","year":"2019","journal-title":"Steroids"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0110|cit110","unstructured":"Review Manager (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"issue":"1","key":"10.1002\/14651858.CD013792.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jclinepi.2014.08.012","article-title":"Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data","volume":"68","author":"Rhodes","year":"2015","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD013792.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ppe.12417","article-title":"Trends in risk of pregnancy loss among US women, 1990-2011","volume":"32","author":"Rossen","year":"2018","journal-title":"Paediatric and Perinatal Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD013792.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD013792.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"e996882","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the quality of evidence from a network meta-analysis","volume":"9","author":"Salanti","year":"2014","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0115|cit115","volume-title":"Myles\u2019 Textbook for Midwives","author":"Shiers","year":"2003"},{"issue":"7458","key":"10.1002\/14651858.CD013792.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"152\u20135","DOI":"10.1136\/bmj.329.7458.152","article-title":"Threatened miscarriage: evaluation and management","volume":"329","author":"Sotiriadis","year":"2004","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013792.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/humrep\/17.2.446","article-title":"Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study","volume":"17","year":"2002","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD013792.pub2-BIB0118|cit118","first-page":"5","article-title":"Development of an Excel spreadsheet for meta-analysis of indirect and mixed treatment comparisons","volume":"88","author":"Tobias","year":"2014","journal-title":"Revista Espanola de Salud Publica"},{"issue":"3","key":"10.1002\/14651858.CD013792.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ije\/dys041","article-title":"Predicting the extent of heterogeneity in meta-analysis,using empirical data from the Cochrane Database of Systematic Reviews","volume":"41","author":"Turner","year":"2012","journal-title":"International Journal of Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD013792.pub2-BIB0120|cit120","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005943.pub5","article-title":"Progestogen for treating threatened miscarriage","author":"Wahabi","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD013792.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1536867X1101100206","article-title":"Multivariate random-effects meta-regression: updates to mvmeta","volume":"11","author":"White","year":"2011","journal-title":"Stata Journal"},{"issue":"4","key":"10.1002\/14651858.CD013792.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/1536867X1501500403","article-title":"Network meta-analysis","volume":"15","author":"White","year":"2015","journal-title":"Stata Journal"},{"issue":"11","key":"10.1002\/14651858.CD013792.pub2-BIB0123|cit123","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013792","article-title":"Progestogens for preventing miscarriage: a network meta-analysis","author":"Devall","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T03:28:50Z","timestamp":1703474930000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013792.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":123,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013792.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,19]]}}}